-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Abivax, Raises Price Target to $150

Benzinga·01/08/2026 10:39:47
语音播报
BTIG analyst Julian Harrison maintains Abivax (NASDAQ:ABVX) with a Buy and raises the price target from $120 to $150.